DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis.
Liling HuangTongji XieFuqiang ZhaoYu FengHao-Hua ZhuLe TangXiao-Hong HanYuan-Kai ShiPublished in: Disease markers (2022)
Our study on an integrated bioinformatical analysis implied that DLX2 could be served as a promising indicator for remodeling tumor microenvironment status and predicting ICI response of patients with LUSC.